Clinical Trial Update: Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CEP-37250/KHK2804 in adults with advanced solid tumors has completed; the conditions include colorectal adenocarcinoma and pancreatic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• CEP-37250 (CEP-37250)
• KHK2804 (KHK2804)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Solid Tumour, Adenocarcinoma of the Colorectal | Phase 1 | Status: COMPLETED